ABSORPTION STUDIES OF THE H-2-BLOCKER NIZATIDINE

被引：27

作者：

KNADLER, MP

BERGSTROM, RF

CALLAGHAN, JT

OBERMEYER, BD

RUBIN, A

机构：

[1] ELI LILLY & CO,LILLY RES LAB,LILLY LAB CLIN RES,INDIANAPOLIS,IN 46285

[2] INDIANA UNIV,SCH MED,DEPT PHARMACOL,INDIANAPOLIS,IN 46202

[3] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 42卷 / 05期

关键词：

D O I：

10.1038/clpt.1987.190

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：514 / 520

页数：7

共 18 条

[1] INTRAVENOUS NIZATIDINE KINETICS AND ACID SUPPRESSION [J].

CALLAGHAN, JT ;

BERGSTROM, RF ;

OBERMEYER, BD ;

KING, EP ;

OFFEN, WW .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) :162-165

[2]

EVANS DC, 1984, FED PROC, V43, P1074

[3] BIOAVAILABILITY AND PHARMACOKINETICS OF CIMETIDINE [J].

GRAHNEN, A ;

BAHR, CV ;

LINDSTROM, B ;

ROSEN, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) :335-340

[4] IMPAIRED CIMETIDINE ABSORPTION DUE TO ANTACIDS AND METOCLOPRAMIDE [J].

GUGLER, R ;

BRAND, M ;

SOMOGYI, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (03) :225-228

[5] THE EFFECT OF METOCLOPRAMIDE AND PROPANTHELINE ON THE GASTROINTESTINAL ABSORPTION OF CIMETIDINE [J].

KANTO, J ;

ALLONEN, H ;

JALONEN, H ;

MANTYLA, R .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (06) :629-631

[6]

KNADLER MP, 1986, DRUG METAB DISPOS, V14, P175

[7]

LIN TM, 1983, GASTROENTEROLOGY, V84, P1231

[8]

LIN TM, 1986, J PHARMACOL EXP THER, V239, P406

[9]

LIN TM, 1986, J PHARMACOL EXP THER, V239, P400

[10]

MARINO AT, 1983, AUST NZ J MED, V13, P325

← 1 2 →